Politics
Trump's Asia Trip and FDA Leadership Changes
President Trump is on a diplomatic visit to China, focusing on security and economic relations. Meanwhile, the departure of Marty Makary from the FDA has raised concerns about organizational stability under the Trump administration.
Coverage timeline — 3 articles
Axios
Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy.But it won't solve the organizational upheaval and pol
2026-05-13 09:30 UTC
Axios
Disagreement among administration officials and a time crunch with President Trump's China summit are holding up efforts to launch a federal response to the next frontier of AI.Why it matters: There's not yet any new federal AI regulation weeks after Mythos — Anthropic's m
2026-05-13 09:30 UTC
Axios
The first half of May is foreshadowing the future of Indo-Pacific security.Why it matters: Long-term competition between the U.S., China and their friends — on
2026-05-13 09:40 UTC